Zimmer Biomet Holdings, Inc. logo
Zimmer Biomet Holdings, Inc. (ZBH)
Compare

Zimmer Biomet Holdings, Inc. (ZBH) Price/FCF Ratio: 9.38

Is Zimmer Biomet Holdings, Inc.’s Price/FCF ratio high or low?

Zimmer Biomet Holdings, Inc.'s Price/FCF ratio of 9.38 is 53% below its 5-year average of 19.96, near the low end of its 5-year range (8.49–37.84).

20.35% below its 12-month average of 11.78.

ZBH Price/FCF Ratio Chart

ZBH Price/FCF Ratio
9.38-30.05% 1Y
Zoom

ZBH Average Price/FCF Ratio Chart

ZBH Current vs Average Price/FCF Ratio Chart

ZBH Price/FCF Ratio Metrics

PRICE/FCF RATIO

9.38

PRICE/FCF RATIO AVG TTM

11.78

PRICE/FCF RATIO AVG 3Y

18.40

PRICE/FCF RATIO AVG 5Y

19.64

PRICE/FCF RATIO AVG 10Y

19.79

PRICE/FCF RATIO AVG 15Y

18.98

PRICE/FCF RATIO AVG 20Y

19.33

CURRENT VS TTM AVG

-20.35%

CURRENT VS 3Y AVG

-49.01%

CURRENT VS 5Y AVG

-52.24%

CURRENT VS 10Y AVG

-52.60%

CURRENT VS 15Y AVG

-50.59%

CURRENT VS 20Y AVG

-51.48%

ZBH Competitors' Price/FCF Ratio

NAMEMARKET CAPPRICE/FCF RATIOTTM3Y5Y
Zimmer Biomet Holdings, Inc. (ZBH)$17.02B9.3811.7818.4019.64
Hologic, Inc. (HOLX)vs ›$16.97B17.1816.1518.1814.60
DaVita Inc. (DVA)vs ›$13.34B9.598.068.738.75
Medpace Holdings, Inc. (MEDP)vs ›$13.14B18.0621.9522.5722.79
Solventum Corporation (SOLV)vs ›$13.06BN/A116.9265.0165.01
Labcorp Holdings Inc. (LH)vs ›$20.98B15.3217.3719.6215.86
Align Technology, Inc. (ALGN)vs ›$13.04B19.0119.0530.8940.36
The Cooper Companies, Inc. (COO)vs ›$12.85B22.5733.7771.4957.96
United Therapeutics Corporation (UTHR)vs ›$22.78B24.9120.2818.0117.69
Revvity, Inc. (RVTY)vs ›$11.16B22.6521.97204.66127.14

Free Cash Flow Valuation

P/FCF Ratio

9.4

FCF Yield

10.66%

Zimmer Biomet Holdings, Inc. Price/FCF Ratio Formula & Definition

P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Zimmer Biomet Holdings, Inc. Price/FCF Ratio FAQ

What is the Price/FCF ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
The Price/FCF ratio for ZBH stock is 9.38.
Is Zimmer Biomet Holdings, Inc.'s Price/FCF ratio high or low?
Zimmer Biomet Holdings, Inc.'s Price/FCF ratio of 9.38 is 53% below its 5-year average of 19.96, near the low end of its 5-year range (8.49–37.84).
What is the TTM average Price/FCF ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
The TTM average Price/FCF ratio for ZBH stock is 11.78.
What is the 3Y average Price/FCF ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
The 3Y average Price/FCF ratio for ZBH stock is 18.40.
What is the 5Y average Price/FCF ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
The 5Y average Price/FCF ratio for ZBH stock is 19.64.
What is the 10Y average Price/FCF ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
The 10Y average Price/FCF ratio for ZBH stock is 19.79.
What is the 15Y average Price/FCF ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
The 15Y average Price/FCF ratio for ZBH stock is 18.98.
What is the 20Y average Price/FCF ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
The 20Y average Price/FCF ratio for ZBH stock is 19.33.

Zimmer Biomet Holdings, Inc. Price/FCF Ratio History

DATEPRICE/FCF RATIO
2026-06-189.38
2026-06-179.30
2026-06-169.53
2026-06-159.42
2026-06-129.45
2026-06-119.30
2026-06-109.41
2026-06-099.56
2026-06-089.31
2026-06-059.32
2026-06-049.25
2026-06-039.07
2026-06-028.93
2026-06-018.85
2026-05-298.78
2026-05-288.83
2026-05-278.81
2026-05-269.00
2026-05-229.12
2026-05-219.10
2026-05-209.11
2026-05-199.18
2026-05-189.08
2026-05-158.93
2026-05-148.82
2026-05-138.82
2026-05-128.89
2026-05-118.49
2026-05-088.78
2026-05-078.89
2026-05-068.84
2026-05-058.86
2026-05-048.82
2026-05-018.84
2026-04-308.83
2026-04-298.58
2026-04-288.87
2026-04-279.92
2026-04-249.78
2026-04-239.91
2026-04-229.97
2026-04-219.93
2026-04-2010.23
2026-04-1710.16
2026-04-1610.16
2026-04-1510.10
2026-04-1410.34
2026-04-1310.22
2026-04-109.98
2026-04-099.97
2026-04-089.97
2026-04-079.80
2026-04-069.75
2026-04-029.74
2026-04-019.76
2026-03-319.69
2026-03-309.50
2026-03-279.49
2026-03-269.55
2026-03-259.39
2026-03-249.25
2026-03-239.41
2026-03-209.42
2026-03-199.63
2026-03-189.55
2026-03-179.92
2026-03-1610.00
2026-03-139.99
2026-03-129.93
2026-03-1110.05
2026-03-109.83
2026-03-0910.00
2026-03-0610.09
2026-03-0510.02
2026-03-0410.26
2026-03-0310.50
2026-03-0210.66
2026-02-2710.55
2026-02-2610.82
2026-02-2510.70
2026-02-2410.70
2026-02-2310.66
2026-02-2010.58
2026-02-1910.64
2026-02-1812.20
2026-02-1712.06
2026-02-1311.98
2026-02-1211.82
2026-02-1111.87
2026-02-1011.35
2026-02-0911.14
2026-02-0611.16
2026-02-0511.02
2026-02-0410.94
2026-02-0310.70
2026-02-0210.71
2026-01-3010.81
2026-01-2910.68
2026-01-2810.64
2026-01-2710.68
2026-01-2610.84
2026-01-2310.75
2026-01-2210.87
2026-01-2110.75
2026-01-2010.78
2026-01-1610.84
2026-01-1511.02
2026-01-1411.08
2026-01-1310.97
2026-01-1211.35
2026-01-0911.53
2026-01-0811.68
2026-01-0711.51
2026-01-0611.76
2026-01-0511.50
2026-01-0211.18
2025-12-3111.16
2025-12-3011.27
2025-12-2911.24
2025-12-2611.27
2025-12-2411.20
2025-12-2311.10
2025-12-2211.15
2025-12-1911.07
2025-12-1811.22
2025-12-1711.37
2025-12-1611.29
2025-12-1511.48
2025-12-1211.37
2025-12-1111.48
2025-12-1011.56
2025-12-0911.46
2025-12-0811.52
2025-12-0511.71
2025-12-0411.57
2025-12-0311.56
2025-12-0211.69
2025-12-0111.77
2025-11-2812.11
2025-11-2612.11
2025-11-2512.05
2025-11-2411.61
2025-11-2111.45
2025-11-2011.06
2025-11-1911.11
2025-11-1811.06
2025-11-1711.01
2025-11-1411.16
2025-11-1311.25
2025-11-1211.18
2025-11-1110.99
2025-11-1011.02
2025-11-0710.99
2025-11-0610.99
2025-11-0510.87
2025-11-0414.37
2025-11-0313.91
2025-10-3114.00
2025-10-3013.87
2025-10-2913.89
2025-10-2814.09
2025-10-2714.36
2025-10-2414.35
2025-10-2314.37
2025-10-2214.48
2025-10-2114.30
2025-10-2014.31
2025-10-1714.19
2025-10-1613.92
2025-10-1513.84
2025-10-1413.70
2025-10-1313.24
2025-10-1013.19
2025-10-0913.56
2025-10-0813.70
2025-10-0713.80
2025-10-0613.76
2025-10-0314.04
2025-10-0213.81
2025-10-0113.77
2025-09-3013.72
2025-09-2913.69
2025-09-2613.68
2025-09-2513.50
2025-09-2413.78
2025-09-2313.97
2025-09-2214.17
2025-09-1913.94
2025-09-1813.96
2025-09-1713.92
2025-09-1613.80
2025-09-1514.06
2025-09-1214.36
2025-09-1114.52
2025-09-1014.25
2025-09-0914.46
2025-09-0814.58
2025-09-0514.72
2025-09-0414.59
2025-09-0314.63
2025-09-0214.62
2025-08-2914.78
2025-08-2814.63
2025-08-2714.87
2025-08-2614.98
2025-08-2514.95
2025-08-2215.00
2025-08-2114.54
2025-08-2014.72
2025-08-1914.53
2025-08-1814.28
2025-08-1514.31
2025-08-1414.22
2025-08-1314.37
2025-08-1214.18
2025-08-1113.93
2025-08-0813.82
2025-08-0713.71
2025-08-0613.50
2025-08-0513.63
2025-08-0413.68
2025-08-0113.42
2025-07-3113.57
2025-07-3013.82
2025-07-2914.06
2025-07-2814.21
2025-07-2514.44
2025-07-2414.34
2025-07-2314.41
2025-07-2214.29
2025-07-2113.71
2025-07-1813.80
2025-07-1714.05
2025-07-1613.95
2025-07-1513.92
2025-07-1413.90
2025-07-1113.89
2025-07-1014.09
2025-07-0914.10
2025-07-0813.84
2025-07-0713.71
2025-07-0313.87
2025-07-0213.84
2025-07-0113.93
2025-06-3013.50
2025-06-2713.54
2025-06-2613.58
2025-06-2513.74
2025-06-2413.67
2025-06-2313.55
2025-06-2013.51
2025-06-1813.41
2025-06-1713.36
2025-06-1613.64
2025-06-1313.51
2025-06-1213.81
2025-06-1113.95
2025-06-1014.05
2025-06-0913.74
2025-06-0613.68

Showing the most recent 260 of 5,032 data points. The chart above shows the full history.

About Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc. (ZBH), along with its global subsidiaries, operates as a leading player in the musculoskeletal healthcare sector. The company extends its reach across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. ZBH is responsible for the design, manufacturing, and marketing of a wide array of orthopedic reconstructive solutions, including prominent knee and hip replacement systems. Their offerings also encompass Specialized Enabling Technologies (S.E.T.) products, which cover areas such as sports medicine, biologics, foot and ankle care, extremity treatments, and trauma management. Furthermore, the company provides medical devices and surgical instruments specifically for spinal conditions, alongside products for facial and cranial reconstruction. A unique part of their portfolio includes systems designed to stabilize and fixate chest bones, facilitating recovery or reconstruction following open-heart surgery, traumatic injuries, or congenital chest deformities. The company's product lines also feature a comprehensive range of dental solutions, such as reconstructive implants, prosthetics, and regenerative materials. Additionally, they are involved in robotic surgical systems, general surgical instruments, and bone cements. These advanced products and solutions are primarily utilized to address conditions in patients suffering from disorders or injuries affecting bones, joints, and their associated soft tissues. Zimmer Biomet caters to a broad clientele, including orthopedic, neuro-, and oral surgeons, dentists, hospitals, independent distributors, healthcare suppliers, and various other medical specialists. Their network further encompasses agents, healthcare purchasing organizations, and group buying alliances. Originally established in 1927, the enterprise was initially known as Zimmer Holdings, Inc., before rebranding as Zimmer Biomet Holdings, Inc. in June 2015. Its corporate headquarters are situated in Warsaw, Indiana.

Warsaw, IN
17,000 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Ivan Tornos